Impax Labs enters into development, manufacturing and commercialization agreement with Perrigo (PRGO); terms not disclosed (IPXL) 20.01 : IPXL announced that it will collaborate with Perrigo (PRGO) on the development, manufacturing and commercialization of an extended topical generic drug product with first to market potential. The product and terms of the agreement were not disclosed.
Market Data 
Markets 
AI
